Francais (Fr)English (United Kingdom)
Recherche
Actualités

Francis Lévi, Warwick Medical School, University of Warwick, July 21, 2014:

- Circadian control of xenobiotic carcinogenesis and cancer pharmacology

- Toward Systems Cancer Chronotherapeutics and its integration into home care 

La Société Francophone de Chronobiologie (SFC) organise son 44ème congrès qui se déroulera du 29-31 octobre 2014

Séance de la Société de Biologie " La chronobiologie " aura lieu le 15 octobre 2014 de 15h00 à 18h00 Institut Curie-Pavillon Curie Amphithéâtre Marie Curie 11, rue Pierre et Marie Curie – Paris 5ème

La soutenance de thèse de Melle Véronique ROCHE sera présentée le 21 mai 2014

Reportage BBC, 13 mai 2014  Chronotherapy: The science of timing drugs to our Body

Journal "Le monde" le 30 avril 2014, "Quand l'horloge biologique se détraque"

 

Voir la suite

Contact

UMRS 935

Equipe3 : Chronothérapie des cancers

et optimisation de la fonction hépatique

INSERM et Université Paris Sud

Bât A 3ème étage Campus CNRS
7 rue Guy Môquet
94801 Villejuif Cedex (France)
Tel :  +33 (0) 1 49 58 34 83
Fax : +33 (0) 1 49 58 34 59
Email:gladys.germe@inserm.fr

Home Production scientifique Publication

2006

Aloia T; Sebagh M., Plasse M., Karam V., Lévi F., Giacchetti S., Azoulay D., Bismuth H., Castaing D., Adam R. : Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J. Clin. Oncol., 2006, 24 : 4983-4990.

Clairambault J., Michel Ph., Perthame B. : Circadian rhythm and tumour growth. C. R. Acad. Sci. (Paris) Ser. I Mathématique 2006, 342 (1) : 17-22.

Filipski E., Li X. M., Lévi F. : Disruption of Circadian Coordination and Malignant Growth ,  Cancer Causes & Control 2006, 17( 4) : 509 – 514. (Invité).

Gholam D., Giacchetti S., Brézault-Bonnet C., Bouchahda M., Hauteville D., Adam R., Ducot B., Ghémard O., Kunstlinger F., Jasmin C., Lévi F. : Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer. The Oncologist, 2006, 11 (10):1072-1080.

Giacchetti S., Bjarnason G., Garufi C., Genet D., Iacobelli S., Tampellini M., Smaaland R., Focan C., Coudert B., Humblet Y., Canon J.L., A. Adenis, Lo Re G., Carvalho C., Schueller J., Anciaux N., Lentz M.A., Baron B., Gorlia T., Lévi F. on behalf the Chronotherapy Group of EORTC : Phase III trial of 4-day chronomodulated vs 2-day conventional delivery of 5-fluorouracil, leucovorin and oxaliplatin as first line chemotherapy of metastatic colorectal cancer by the EORTC chronotherapy group. J. Clin. Oncol., 2006, 24 : 3562-3569.

Iurisci I., Filipski E., Reinhardt J., Bach S., Gianella-Borradori A., Iacobelli S., Meijer L., Lévi F. : Improved tumor control through circadian clock induction by seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res., 2006; 66 (22) : 10720-10728.

Lévi F. : Chronotherapeutics: The Relevance of Timing in Cancer Therapy,  Cancer Causes & Control 2006, 17 (4) : 611 – 621. (Invité).

Lévi F. : The circadian timing system, a coordinator of life processes. Implications for the rhythmic delivery of cancer therapeutics. 28th Annual Conference IEEE Engineering in Medicine and Biology Society, IEEE EMBC 2006, New York, U.S.A., August 30th - September 2nd 2006, Proceedings, 2006, 6736-6739.

Li X.M., Kanekal S., Crépin D., Guettier C., Carrière J., Elliott G., Lévi F. : Circadian pharmacology of L-Alanosine (SDX-102) in mice. Molecular Cancer Therapeutics, 2006, 5 (2) : 337-346.

Tsinkalovsky O., Filipski E., Rosenlund B., Sothern R.B., Eiken H.G., Wu M.W., Claustrat B., Bayer J., Lévi F., Laerum O.D. : Circadian expression of clock genes in purified hematopoietic stem cells is developmentally regulated in mouse bone marrow. Exp. Hematol., 2006, 34 : 1248-1260.

<-Retour

 

Mise à jour le : 22/04/2015

Copyright © 2011 ---.
All Rights Reserved